- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01362634
A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
December 6, 2017 updated by: Steven Kurtz, Ph.D., Nova Southeastern University
The proposed study is a three-armed randomized clinical trial.
A total of 750 clients will be randomly assigned (using a random number table) to the interviewer-administered intervention, the self-administered intervention, and waitlist control conditions upon completion of screening, informed consent, HIV pretest counseling and test administration, and collection of baseline risk behavior data.
Outcomes will be measured at 3, 6 and 12 months.
Study Overview
Status
Completed
Conditions
Detailed Description
The specific aims of the 5-year study are to:
- identify the covariates of baseline substance abuse and sexual risks (including demographics, social risk measures, peer norms, abuse history, and mental health status) among a sample of 750 heterosexually active, not-in-treatment, club and prescription drug users ages 18 to 39 in Miami, Florida.
evaluate, through random assignment, the relative effectiveness of two intervention conditions and a waitlist control in reducing sex risks and drug use, as measured at 3-, 6- and 12-month follow-ups:
- Arm 1, an interviewer-administered comprehensive health and social risk assessment intervention (CAPI Intervention) similar to the baseline instrument used in the parent grant;
- Arm 2, an identical self-administered comprehensive assessment intervention (ACASI Intervention); and
- Arm 3, a waitlist control condition (Control). Outcome measures, including past 90-day counts of unprotected sex acts and days' drug use, will be obtained from brief risk behavior inventories at baseline and follow-ups.
- conduct qualitative process evaluation research with 40 participants in each study arm to contextualize the study findings and intervention outcomes.
Study Type
Interventional
Enrollment (Actual)
750
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33137
- NSU Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- heterosexually active
- ongoing club and prescription drug use
- between 18-39 years of age
- must go to local clubs at least two times per month
Exclusion Criteria:
- no current working phone number or e-mail address
- no intention to remain in South Florida for the next 12 months
- new HIV diagnosis in the past 90 days
- currently participating in a drug treatment program (excluding 12-step programs such as Alcoholics Anonymous)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CAPI Intervention
an interviewer-administered comprehensive health and social risk assessment intervention
|
interviewer-administered intervention
|
|
Experimental: ACASI Intervention
self-administered comprehensive health and social risk assessment intervention
|
self-administered, computer-based intervention
|
|
No Intervention: Control
waitlist control condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
unprotected sexual intercourse events outside of primary relationships
Time Frame: 3 months
|
3 months
|
|
unprotected sexual intercourse events outside of primary relationship
Time Frame: 6 months
|
6 months
|
|
unprotected sexual intercourse events outside of primary relationship
Time Frame: 12 months
|
12 months
|
|
Days drug use in the past 90 days
Time Frame: 3 months
|
3 months
|
|
Days drug use in the past 90 days
Time Frame: 6 months
|
6 months
|
|
Days drug use in the past 90 days
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
July 31, 2017
Study Registration Dates
First Submitted
May 26, 2011
First Submitted That Met QC Criteria
May 26, 2011
First Posted (Estimate)
May 30, 2011
Study Record Updates
Last Update Posted (Actual)
December 7, 2017
Last Update Submitted That Met QC Criteria
December 6, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7R01DA019048 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infection
-
Federal University of São PauloGilead SciencesCompleted
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Fundación HuéspedViiV HealthcareNot yet recruitingHIV-1-infectionArgentina, Brazil
-
Fundación HuéspedMSD Pharmaceuticals LLC; Fundacion IDEAANot yet recruiting
-
Henan Genuine Biotech Co., Ltd.Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
BioNTech SERecruitingHIV -1 InfectionGermany, United States
-
TaiMed Biologics Inc.Active, not recruitingHIV -1 InfectionUnited States
-
University of North Carolina, Chapel HillNot yet recruiting
-
Craig Cohen, MD, MPHNational Institute of Allergy and Infectious Diseases (NIAID); Duke University and other collaboratorsRecruiting
Clinical Trials on Trans-theoretical Process of Change Model - interviewer
-
Queen Mary University of LondonRecruiting
-
Yale UniversityNational Institute of Nursing Research (NINR)Completed
-
Ege UniversityCompleted
-
Assuta Hospital SystemsCompleted
-
Beijing Municipal Health CommissionExhibition Road Community Health Service Center of Xicheng District, Beijing... and other collaboratorsRecruitingAtrial FibrillationChina
-
Alcon, a Novartis CompanyCompletedExudative Age-Related Macular DegenerationUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)RecruitingClinical High Risk for Psychosis (CHR)Tunisia
-
Chinese University of Hong KongRecruitingNon Communicable Diseases | Health-risk BehavioursHong Kong
-
Roswell Park Cancer InstituteRecruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States